{
  "id": 14271,
  "label": "pancreatic cancer, susceptibility to, 2",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MONDO:0013235",
  "properties": {
    "xrefs": [
      "GARD:0027845",
      "MEDGEN:461896",
      "OMIM:613347",
      "UMLS:C3150546"
    ],
    "synonyms": [
      "BRCA2 familial pancreatic carcinoma",
      "familial pancreatic carcinoma caused by mutation in BRCA2",
      "pancreatic cancer 2",
      "pancreatic cancer, susceptibility to, 2",
      "pancreatic cancer, susceptibility to, type 2",
      "Pnca2",
      "susceptibility to pancreatic cancer 2"
    ],
    "categories": [
      {
        "ref": "MONDO:0002254",
        "name": "syndromic disease"
      }
    ],
    "definition": "Any familial pancreatic carcinoma in which the cause of the disease is a mutation in the BRCA2 gene."
  },
  "isLeaf": true,
  "isRoot": false,
  "child_count": 0,
  "parents": [
    {
      "id": 24664,
      "label": "BRCA2-related cancer predisposition",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        16218
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "GARD:0026409"
        ],
        "categories": [
          {
            "ref": "MONDO:0002254",
            "name": "syndromic disease"
          }
        ],
        "definition": "Hereditary cancer predisposition due to variation(s) in the BRCA2 gene. Germline pathogenic or likely pathogenic variants in the BRCA2 gene confer an autosomal dominant predisposition to hereditary breast and ovarian cancer. Tumor formation at other sites, including pancreatic and prostate cancer, have been described."
      },
      "child_count": 3,
      "reference_id": "MONDO:0700269"
    }
  ],
  "children": [],
  "roots": [
    {
      "id": 24664,
      "label": "BRCA2-related cancer predisposition"
    }
  ]
}